Patent 8447607

PTAB challenges

AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.

Active provider: Google · gemini-2.5-flash

Proceedings on file (1)

All PTAB activity →

AIA trial proceedings (IPR / PGR / CBM) filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced from the USPTO Open Data Portal and refreshed every six hours; each proceeding number deep-links to the PTAB E2E docket.

1 discretionary denial
Discretionary Denial
Filed
Jul 25, 2025
Last modified
Mar 4, 2026
Petitioner
Meta Platforms, Inc.
Inventor
CHRIS WEIDER et al

PTAB challenges

AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.

✓ Generated

Proceedings overview

One AIA trial proceeding has been filed against US Patent 8,447,607, which is currently in a "Discretionary Denial" status. This means the petition for inter partes review was not instituted by the PTAB. For a defendant, this indicates the patent claims remain untested by this specific IPR challenge, suggesting a stronger defensive posture for the patent owner against similar challenges.

IPR2025-01332 — Meta Platforms, Inc. v. CHRIS WEIDER et al

  • Type: Inter Partes Review
  • Filed: 2025-07-25
  • Status: Discretionary Denial - The Patent Trial and Appeal Board (PTAB) declined to institute an inter partes review.
  • Judge panel: Not publicly available at this stage.
  • Petition grounds: Not publicly available for discretionary denials without institution.
  • Institution decision: Denied - 2026-03-04. The panel's reasoning for the discretionary denial would be outlined in the institution decision itself, typically involving factors like parallel litigation, advanced stage of litigation, or inefficient use of Board resources.
  • Final Written Decision: Not issued, as institution was denied.
  • Settlement / termination: Not applicable, as institution was denied.
  • Appeal: Not applicable, as institution was denied.
  • Defensive value: The patent owner prevailed in this instance, as the PTAB exercised its discretion to deny institution of the IPR. This means the claims that were challenged in this petition have not been invalidated by this IPR proceeding. Any future IPR-based defense for similar grounds might face the precedent of this discretionary denial, potentially making such challenges harder.

Strategic summary

As of the current date, US Patent 8,447,607 has one filed AIA trial proceeding, IPR2025-01332, which was denied institution on 2026-03-04. This means all claims of 8,447,607 remain UNTESTED by this IPR and are therefore SUSTAINED against this particular challenge. There are no claims canceled as a result of PTAB proceedings for this patent based on the provided information.

Regarding estoppel, since IPR2025-01332 was denied institution, the statutory estoppel provisions of 35 U.S.C. § 315(e)(2) for inter partes review do not apply to the petitioner, Meta Platforms, Inc., or their privies for this proceeding. This is because estoppel typically only arises after a final written decision in an instituted IPR. Therefore, the prior art grounds that could have been raised in this petition are technically still available for other parties, or potentially even for Meta Platforms, Inc. in certain contexts, though a subsequent petition by the same petitioner on similar grounds might face similar discretionary denial challenges.

The single proceeding filed by Meta Platforms, Inc. suggests an attempt by a potential defendant to challenge the patent's validity. The discretionary denial indicates the PTAB found reasons beyond the merits of the prior art to not proceed with the trial. There is no pattern of multiple IPRs from the same petitioner or aggressive PTAB appeals by the patent owner visible from this single proceeding.

Recommended next steps

The institution decision for IPR2025-01332 was a discretionary denial, meaning the patent claims were not substantively reviewed for patentability in this proceeding. For a defendant facing assertion of this patent, it would be crucial to review the PTAB's decision denying institution to understand the specific reasoning. This can inform future defensive strategies, particularly regarding whether to pursue a new IPR challenge and how to address any discretionary factors that led to the denial in IPR2025-01332. The denial means the patent claims are still presumed valid and have not been narrowed by this IPR.

No further PTAB trial stage milestones are pending for IPR2025-01332 as the proceeding was not instituted.

Generated 5/21/2026, 12:46:12 AM